See also this year's filing and all EDGAR filings for this company.
PDF Report 0001270073_2016_Intercept_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001270073, Intercept Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 641,693,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 10,047,000 |
| 3 | remainder_Assets | 4,018,000 |
| 4 | LiabilitiesCurrent | 47,373,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 6,236,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 103,745,000 |
| 9 | ResearchAndDevelopmentExpense | 128,193,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 5,509,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 655,758,000 |
| 1 | Liabilities | 53,609,000 |
| 2 | Expenses | 231,938,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 602,149,000 |
| 5 | NetIncome | -226,429,000 |
| 6 | ComprehensiveNetIncome | -226,429,000 |
| 7 | BaseVar | 473,407,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.06 |
| 9 | EconomicCapitalRatio | 3.73 |
Edgar->Model Mapping
Feature Distribution
